Key Takeaways
- Taiwan Semiconductor’s 2nm manufacturing capacity is completely reserved through 2028 and likely beyond
- The chip giant may be forced to restructure its upcoming Feynman AI architecture
- Meta and other tech giants are vying for the same limited TSMC production slots
- TSMC plans consecutive annual price increases through 2029 amid overwhelming demand
- Wall Street analysts continue rating NVDA as a Strong Buy with a $274.03 average target price
Shares of Nvidia tumbled Monday following revelations that a severe manufacturing bottleneck at Taiwan Semiconductor Manufacturing Company could necessitate a complete overhaul of its Feynman AI chip architecture. The stock closed down 3.28%, while TSMC shares fell 2.82% during the same trading session.
According to an initial report from Taiwan’s Economic Daily News, TSMC’s cutting-edge 2-nanometer production facilities are operating at full capacity with commitments stretching to 2028 and potentially further. The unprecedented demand from artificial intelligence and high-performance computing clients has created a supply crisis at the world’s dominant contract semiconductor manufacturer.
The Feynman platform represents NVIDIA’s forthcoming data center chip architecture, which was announced during the company’s GTC 2026 conference. Positioned as the follow-up to the Vera Rubin generation, Feynman was originally slated for commercial availability in 2028.
The core issue is straightforward: insufficient 2nm production capacity exists to manufacture Feynman according to its current specifications. This reality is compelling Nvidia to explore alternative design approaches well ahead of the platform’s intended launch date.
TSMC Faces Unprecedented Demand Across Multiple Clients
TSMC’s 2-nanometer manufacturing process, including the sophisticated A16 variation, delivers performance improvements ranging from 15% to 25% compared to previous generation technologies. These efficiency gains make the nodes particularly attractive for demanding artificial intelligence applications.
Nvidia isn’t alone in pursuing these limited manufacturing slots. Meta has emerged as a fierce competitor, placing substantial orders for specialized AI processors and graphics chips to power its expanding data center infrastructure. Apple currently controls more than half of all early-stage 2nm orders, effectively pushing other customers further back in the production schedule.
Nvidia reportedly commands approximately 20% of TSMC’s most advanced manufacturing capacity and has secured the majority of CoWoS advanced packaging availability through 2026. CEO Jensen Huang is reportedly engaging directly with TSMC leadership to maximize production allocation.
Despite this preferential treatment, even Nvidia cannot escape the capacity constraints. Client waiting lists now extend past 2028, and TSMC has announced plans for consecutive yearly price increases through 2029 to compensate for escalating operational expenses.
Vera Rubin Platform Remains on Schedule
While the Feynman architecture faces uncertainty, Nvidia’s more immediate Vera Rubin platform continues progressing according to plan. Vera Rubin is expected to commence shipments within the current year, well before the Feynman deployment window.
Nvidia has successfully reserved A16 manufacturing capacity for both its Rubin Ultra chips and subsequent GPU generations following Vera Rubin. The most severe capacity shortage appears concentrated around the Feynman timeframe, which sits further along the company’s product roadmap.
TSMC has publicly confirmed the surge in customer demand and indicated intentions to expand production capabilities over time. However, the company has not provided specific timelines for when the current capacity constraints might ease.
Certain industry observers have suggested Intel and Samsung as potential alternative manufacturing partners, though neither currently possesses TSMC’s advanced process technology capabilities at commercial scale.
Wall Street analysts tracking NVDA maintain optimistic long-term outlooks. According to TipRanks data, the stock holds a Strong Buy consensus rating from 41 analysts, with only a single Hold recommendation. The average analyst price target stands at $274.03, suggesting approximately 58.7% potential upside from present trading levels.
NVDA finished Monday’s session down 3.28%. TSM declined 2.82% during the same trading period.


